| scholarly article | Q13442814 |
| P2093 | author name string | Chantal Guillemette | |
| Marie Plante | |||
| Jean Grégoire | |||
| Lyne Villeneuve | |||
| Yannick Audet-Delage | |||
| P2860 | cites work | Acylcarnitines: reflecting or inflicting insulin resistance? | Q27004603 |
| Endometrial Carcinoma: Role of Current and Emerging Biomarkers in Resolving Persistent Clinical Dilemmas | Q28074769 | ||
| High resolution mass spectrometry coupled with multivariate data analysis revealing plasma lipidomic alteration in ovarian cancer in Asian women | Q31042430 | ||
| Obesity-related hormones and endometrial cancer among postmenopausal women: a nested case–control study within the B∼FIT cohort | Q33684880 | ||
| Chemoproteomic Profiling of Bile Acid Interacting Proteins | Q33731122 | ||
| The prognostic value of plasma fibrinogen levels in patients with endometrial cancer: a multi-centre trial | Q33747342 | ||
| Prognostic factors for tumor recurrence in endometrioid endometrial cancer stages IA and IB | Q33760587 | ||
| Metabolic profiling and novel plasma biomarkers for predicting survival in epithelial ovarian cancer | Q33762042 | ||
| Role of aldo-keto reductase family 1 (AKR1) enzymes in human steroid metabolism | Q34382405 | ||
| The mechanisms by which polyamines accelerate tumor spread | Q35505118 | ||
| The Epidemiology of Endometrial and Ovarian Cancer | Q35676052 | ||
| Personalized therapy in endometrial cancer: Challenges and opportunities | Q35911350 | ||
| Analysis of serum metabolic profiles in women with endometrial cancer and controls in a population-based case-control study | Q36201522 | ||
| Long-term dietary heme iron and red meat intake in relation to endometrial cancer risk | Q50504161 | ||
| Saturated fatty acids as possible important metabolites for epithelial ovarian cancer based on the free and esterified fatty acid profiles determined by GC-MS analysis | Q51113701 | ||
| Discovery of biomarkers for endometrial cancer: current status and prospects | Q51341963 | ||
| Transgenic Overexpression of Steroid Sulfatase Alleviates Cholestasis | Q57128738 | ||
| Profiling of Endogenous Estrogens, Their Precursors, and Metabolites in Endometrial Cancer Patients: Association with Risk and Relationship to Clinical Characteristics | Q57635215 | ||
| Pharmacogenomics of Human Uridine Diphospho-Glucuronosyltransferases and Clinical Implications | Q62835509 | ||
| Effect of choline esters and oleic acid on the penetration of acyclovir, estradiol, hydrocortisone, nitroglycerin, retinoic acid and trifluorothymidine across hairless mouse skin in vitro | Q69265504 | ||
| Estrone sulfate and sulfatase activity in human breast cancer and endometrial cancer | Q69363493 | ||
| Activation of human endometrial phospholipase D by bradykinin | Q70970773 | ||
| ROC analysis | Q81320825 | ||
| Immunohistochemical and functional studies on calcium-sensing receptors in rat uterine smooth muscle | Q82113853 | ||
| Endometrial cancer cells can express fibrinogen: Immunohistochemistry and RT-PCR analysis | Q86494388 | ||
| Metabolomic prediction of endometrial cancer | Q92105040 | ||
| Predictive and prognostic factors in definition of risk groups in endometrial carcinoma. | Q36417927 | ||
| The BUME method: a novel automated chloroform-free 96-well total lipid extraction method for blood plasma. | Q36520373 | ||
| Analysis of matched case-control studies | Q36629740 | ||
| Mass spectrometry images acylcarnitines, phosphatidylcholines, and sphingomyelin in MDA-MB-231 breast tumor models. | Q36658347 | ||
| Serum Estrogens and Estrogen Metabolites and Endometrial Cancer Risk among Postmenopausal Women | Q37059802 | ||
| Molecular pathogenesis of endometrial and ovarian cancer | Q37293672 | ||
| Preoperative CA125 and fibrinogen in patients with endometrial cancer: a risk model for predicting lymphovascular space invasion | Q37662462 | ||
| Pre-operative systemic inflammatory response markers in predicting lymph node metastasis in endometrioid endometrial adenocarcinoma | Q37996683 | ||
| The use of zebrafish as a model system for investigating the role of the SULTs in the metabolism of endogenous compounds and xenobiotics | Q38136700 | ||
| The role of monoacylglycerol lipase (MAGL) in the cancer progress | Q38196323 | ||
| The Significance of the Sulfatase Pathway for Local Estrogen Formation in Endometrial Cancer | Q38687447 | ||
| Emerging applications of metabolomics in drug discovery and precision medicine | Q38769103 | ||
| Endometrioid endometrial adenocarcinoma: an increase of G3 cancers? | Q38831227 | ||
| Alterations in the mitochondrial responses to PENAO as a mechanism of resistance in ovarian cancer cells. | Q38863473 | ||
| Alterations of choline phospholipid metabolism in endometrial cancer are caused by choline kinase alpha overexpression and a hyperactivated deacylation pathway | Q38952134 | ||
| Integrative Systemic and Local Metabolomics with Impact on Survival in High-Grade Serous Ovarian Cancer | Q39231950 | ||
| Screening and verifying endometrial carcinoma diagnostic biomarkers based on a urine metabolomic profiling study using UPLC-Q-TOF/MS. | Q39246425 | ||
| Mechanisms of bile acid mediated inflammation in the liver | Q39367594 | ||
| Expression patterns of kinin-dependent genes in endometrial cancer | Q39601308 | ||
| Activation of kinin B1 receptor increases the release of metalloproteases-2 and -9 from both estrogen-sensitive and -insensitive breast cancer cells. | Q39621565 | ||
| The levels of the endocannabinoid receptor CB2 and its ligand 2-arachidonoylglycerol are elevated in endometrial carcinoma | Q39743487 | ||
| Plasma and ovarian tissue sphingolipids profiling in patients with advanced ovarian cancer | Q40085782 | ||
| Endometrial Cancer Risk Factors, Hormone Receptors, and Mortality Prediction | Q40396155 | ||
| Paracrine inducers of uterine endometrial spermidine/spermine N1-acetyltransferase gene expression during early pregnancy in the pig. | Q41001628 | ||
| Estrogen Metabolism and Risk of Postmenopausal Endometrial and Ovarian Cancer: the B ∼ FIT Cohort | Q41002144 | ||
| Linking the ceramide synthases (CerSs) 4 and 5 with apoptosis, endometrial and colon cancers | Q41206952 | ||
| Metabolomics of biomarker discovery in ovarian cancer: a systematic review of the current literature | Q41403906 | ||
| Enhanced expression of hydroxylated ceramide in well-differentiated endometrial adenocarcinoma. | Q41870876 | ||
| Circulating estrogens in endometrial cancer cases and their relationship with tissular expression of key estrogen biosynthesis and metabolic pathways. | Q43108091 | ||
| Altered sphingolipid metabolism in human endometrial cancer. | Q43131360 | ||
| Prognostic significance of preoperative plasma fibrinogen in endometrial cancer. | Q43711405 | ||
| Human monoclonal antibody (HMST-1) against lacto-series type 1 chain and expression of the chain in uterine endometrial cancers | Q44196399 | ||
| Bile acids increase response and expression of human myometrial oxytocin receptor | Q44603395 | ||
| Glycine consumption and mitochondrial serine hydroxymethyltransferase in cancer cells: the heme connection | Q44655377 | ||
| Reconstitution into liposomes and functional characterization of the carnitine transporter from renal cell plasma membrane | Q44766784 | ||
| Expression of sulfatide and sulfated lactosylceramide among histological types of human ovarian carcinomas. | Q46840045 | ||
| EGR1 regulates cellular metabolism and survival in endocrine resistant breast cancer. | Q47122770 | ||
| Novel algorithm including CA-125, HE4 and body mass index in the diagnosis of endometrial cancer | Q47314904 | ||
| Metabolomic Signature of Endometrial Cancer. | Q47565675 | ||
| Estradiol metabolites as biomarkers of endometrial cancer prognosis after surgery | Q47631203 | ||
| Augmentation of arginase Ⅱ expression in the human endometrial epithelium in the secretory phase | Q47906384 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P921 | main subject | biomarker | Q864574 |
| endometrial cancer | Q944777 | ||
| P304 | page(s) | 87 | |
| P577 | publication date | 2018-03-12 | |
| P1433 | published in | Frontiers in Endocrinology | Q27723680 |
| P1476 | title | Identification of Metabolomic Biomarkers for Endometrial Cancer and Its Recurrence after Surgery in Postmenopausal Women | |
| P478 | volume | 9 |
Search more.